YASUO UCHIDA

Last Updated :2026/07/06

Affiliations, Positions
Graduate School of Biomedical and Health Sciences, Professor
E-mail
yuchidahiroshima-u.ac.jp
Self-introduction
I was born in Oyama City, Tochigi Prefecture, Japan, and graduated from Oyama Jonan Junior High School and Tochigi High School. I spent my student days at Tohoku University Faculty of Pharmaceutical Sciences, where I worked as an assistant, assistant professor (studied at ETH Zurich as a JSPS overseas fellow for two years), lecturer and associate professor before moving to my current position at the Graduate School of Biomedical and Health Sciences, Hiroshima University in April 2023. I am developing cutting-edge research surrounded by students who are highly motivated in their research. We possess the technology to simultaneously quantify the abundance of thousands of proteins with high accuracy and sensitivity for membrane proteins by quantitative proteomics, which can be applied to a wide variety of samples, including frozen and FFPE human tissues, animals, cells, plants, insects and micro-organisms (The Young Scientists' Award, The Commendation for Science and Technology by the Minister of Education, Culture, Sports, Science and Technology). We aim to open up the next generation of pharmaceutics called 'Molecular Systems Pharmaceutics', and to elucidate the mysteries of the brain, brain activity and the molecular mechanisms of human central nervous system disorders, as well as drug discovery for those disorders. We are currently recruiting staff and graduate students, so please feel free to contact us. E-mail, yuchida@hiroshima-u.ac.jp

Basic Information

Major Professional Backgrounds

  • 2023/04/01, Hiroshima University, Graduate School of Biomedical and Health Sciences, Professor
  • 2023/03/01, 2023/03/31, Tohoku University, Graduate School of Pharmaceutical Sciences, Associate Professor
  • 2018/09/01, 2023/02/28, Tohoku University, Graduate School of Pharmaceutical Sciences, Lecturer
  • 2014/04/01, 2016/03/31, ETH Zurich, Institute of Molecular Systems Biology (IMSB), Postdoctral Fellowship for Research Abroad
  • 2012/02/01, 2018/08/31, Tohoku University, Graduate School of Pharmaceutical Sciences, Assistant Professor
  • 2010/04/01, 2012/01/31, Tohoku University, Graduate School of Pharmaceutical Sciences, Research Associate
  • 2008/04/01, 2010/03/31, Tohoku University, Graduate School of Pharmaceutical Sciences, JSPS Research Fellowship for Young Scientists (DC1) (Ph.D. course student)

Educational Backgrounds

  • Tohoku University, Graduate School of Pharmaceutical Sciences, Ph.D. degree, Japan, 2012/01/18
  • Tohoku University, Graduate School of Pharmaceutical Sciences, Ph.D. course, Japan, 2008/04/01, 2010/03/31
  • Tohoku University, Graduate School of Pharmaceutical Sciences, Master course, Japan, 2006/04/01, 2008/03/31
  • Tohoku University, Faculty of Pharmaceutical Sciences, Japan, 2002/04/01, 2006/03/31
  • Tochigi High School, 1999/04/01, 2002/03/31
  • Oyama Jounan Junior High School, 1996/04/01, 1999/03/31

Academic Degrees

  • TOHOKU UNIVERSITY
  • TOHOKU UNIVERSITY

Research Fields

  • Medicine,dentistry, and pharmacy;Pharmacy;Medical pharmacy
  • Complex systems;Biomedical engineering;Biomedical engineering / Biomaterial science and engineering
  • Medicine,dentistry, and pharmacy;Basic medicine;Experimental pathology
  • Medicine,dentistry, and pharmacy;Pharmacy;Pharmacology in pharmacy

Research Keywords

  • Quantitative proteomics of a variety of species including human tissue and membrane proteins (Simultaneous quantification of thousands of proteins)
  • The studies using human brain and spinal cord
  • Barrier regulation
  • Barrier systems biology
  • Central nervous system barrier drug discovery
  • Pharmaceutics
  • Pharmacokinetics

Affiliated Academic Societies

  • The Pharmaceutical Society of Japan
    Related URL
  • The Japanese Society for the Study of Xenobiotics
    Related URL
  • The Academy of Pharmaceutical Science and Technology, Japan
    Related URL
  • International Society for Neurochemistry (Handling Editor of Journal of Neurochemistry)
    Related URL
  • International Brain Barrier Society
    Related URL
  • Human Proteome Organization
    Related URL
  • International Society of Study on Xenobiotics
    Related URL
  • American Association of Pharmaceutical Scientists
    Related URL
  • Japan Transporter Research Association
    Related URL

Educational Activity

Course in Charge

  1. 2026, Undergraduate Education, 2Term, Functional Morphology
  2. 2026, Undergraduate Education, Intensive, Functional Morphology
  3. 2026, Undergraduate Education, 3Term, Biopharmaceutics
  4. 2026, Undergraduate Education, First Semester, Research Practice A
  5. 2026, Undergraduate Education, Second Semester, Research Practice B
  6. 2026, Undergraduate Education, First Semester, Practice of Drug Delivery System
  7. 2026, Undergraduate Education, 1Term, Pharmacokinetics
  8. 2026, Undergraduate Education, Intensive, Pharmacokinetics
  9. 2026, Undergraduate Education, 3Term, Japanese Pharmacopoeia
  10. 2026, Undergraduate Education, First Semester, Practice of Pharmaceutics
  11. 2026, Undergraduate Education, Year, Special laboratory Works in Pharmaceutical Sciences I
  12. 2026, Undergraduate Education, Year, Special laboratory Works in Pharmaceutical Sciences II
  13. 2026, Undergraduate Education, Second Semester, Special laboratory Works in Pharmaceutical Sciences III
  14. 2026, Undergraduate Education, Year, Special laboratory Works in Clinical Pharmacy I
  15. 2026, Undergraduate Education, Year, Special laboratory Works in Clinical Pharmacy II
  16. 2026, Undergraduate Education, Year, Special laboratory Works in Clinical Pharmacy III
  17. 2026, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar on Molecular Systems Pharmaceutics
  18. 2026, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar on Molecular Systems Pharmaceutics
  19. 2026, Graduate Education (Doctoral Program) , First Semester, Advanced Research on Molecular Systems Pharmaceutics
  20. 2026, Graduate Education (Doctoral Program) , Second Semester, Advanced Research on Molecular Systems Pharmaceutics
  21. 2026, Graduate Education (Master's Program) , First Semester, Lecture on Medicinal Science
  22. 2026, Graduate Education (Doctoral Program) , First Semester, Advanced Lecture on Medicinal Science
  23. 2026, Graduate Education (Master's Program) , First Semester, Seminar on Drug Delivery Sciences
  24. 2026, Graduate Education (Master's Program) , Second Semester, Seminar on Drug Delivery Sciences
  25. 2026, Graduate Education (Master's Program) , First Semester, Seminar on Molecular Systems Pharmaceutics
  26. 2026, Graduate Education (Master's Program) , Second Semester, Seminar on Molecular Systems Pharmaceutics
  27. 2026, Graduate Education (Master's Program) , First Semester, Advanced Research on Molecular Systems Pharmaceutics
  28. 2026, Graduate Education (Master's Program) , Second Semester, Advanced Research on Molecular Systems Pharmaceutics
  29. 2026, Graduate Education (Master's Program) , Second Semester, Lecutre on Molecular Systems Pharmaceutics
  30. 2026, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar on Molecular Systems Pharmaceutics
  31. 2026, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar on Molecular Systems Pharmaceutics
  32. 2026, Graduate Education (Doctoral Program) , First Semester, Advanced Research on Molecular Systems Pharmaceutics
  33. 2026, Graduate Education (Doctoral Program) , Second Semester, Advanced Research on Molecular Systems Pharmaceutics

Research Activities

Academic Papers

  1. Ataxin-2 as a candidate blood biomarker for estimating disease status in cases of suspected glioblastoma recurrence, BRAIN TUMOR PATHOLOGY, 43(2), 43-55, 202604
    Link to Paper Search Results by DOI
  2. Systematic Evaluation of BBB-Penetrant AAV Capsids in Marmosets Identifies VCAP-102 as a Highly Efficient Brain-Transducing Capsid, Molecular Therapy Advances, 202606
    Link to Paper Search Results by DOI
  3. ★, Inflammatory reprogramming of alveolar macrophages by the bacterial peptide iE-DAP via PEPT2 transport, Toxicological Research, 20260124
    Link to Paper Search Results by DOI
  4. Zinc-MTF1-metallothionein axis plays critical roles in the defense against ferroptosis in human cells, FREE RADICAL BIOLOGY AND MEDICINE, 245, 390-404, 20260301
    Link to Paper Search Results by DOI
  5. ★, Altered astrocyte-neuron crosstalk in progressive supranuclear palsy: integrated evidence from proteomics and magnetic resonance spectroscopy, ACTA NEUROPATHOLOGICA, 151(1), 20260424
    Link to Paper Search Results by DOI
  6. Cigarette Smoke Extract Suppresses PEPT2 Function in Alveolar Epithelial Cells via Aryl Hydrocarbon Receptor Signaling, Toxicological Sciences, 209(5), kfag056, 20260519
    Link to Paper Search Results by DOI
  7. ★, miR-PAIR: microRNA-protein analysis of integrative relationship for the identification of significantly working miRNAs, BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1869(2), 202502
    Link to Paper Search Results by DOI
  8. Biological role and clinicopathological significance of leucine-rich α-2 glycoprotein 1 in the glioblastoma microenvironment, JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 84(8), 707-714, 202508
    Link to Paper Search Results by DOI
  9. Stoichiometric transport of estrone 3-sulfate among genetic variants of OATP1A2 and OATP2B1 and structural analysis by molecular dynamics simulation: Impairment of gating mechanism in the unstable inward-open conformation of OATP2B1 (Asp215Val) significantly suppress the transport activity, DRUG METABOLISM AND DISPOSITION, 53(12), 202512
    Link to Paper Search Results by DOI
  10. SWATH-MS-based functional analysis of metal transporters, Seitainokagaku, 75(2), 116-121, 2024
  11. Blood-Arachnoid Barrier: A new central nervous system barrier having different transport molecular mechanisms from blood-brain barrier, Membrane, 49(2), 99-106, 2024
  12. Activation of prefrontal parvalbumin interneurons ameliorates working memory deficit even under clinically comparable antipsychotic treatment in a mouse model of schizophrenia, Neuropsychopharmacology, 49(4), 720-730, 2024
  13. The Effects of N-Glycosylation on the Expression and Transport Activity of OATP1A2 and OATP2B1, JOURNAL OF PHARMACEUTICAL SCIENCES, 113(5), 1376-1384, 202405
    Link to Paper Search Results by DOI
  14. ZNT5-6 and ZNT7 play an integral role in protein N-glycosylation by supplying Zn2+ to Golgi alpha-mannosidase II, JOURNAL OF BIOLOGICAL CHEMISTRY, 300(6), 202406
    Link to Paper Search Results by DOI
  15. ★, Abemaciclib-induced epithelial-mesenchymal transition mediated by cyclin-dependent kinase 4/6 independent of cell cycle arrest pathway, INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 172, 202407
    Link to Paper Search Results by DOI
  16. Aggregability of the SQSTM1/p62-based aggresome-like induced structures determines the sensitivity to parthanatos, CELL DEATH DISCOVERY, 10(1), 20240212
    Link to Paper Search Results by DOI
  17. Transporter Protein Expression of Corneal Epithelium in Rabbit and Porcine: Evaluation of Models for Ocular Drug Transport Study, MOLECULAR PHARMACEUTICS, 21(7), 3204-3217, 20240529
    Link to Paper Search Results by DOI
  18. Next generation quantitative proteomics-based central nervous system barrier transporter studies, Pharmaceutics, 83, 72-77, 2023
  19. Characterization of proteome profile data of chemicals based on data-independent acquisition MS with SWATH method, NAR Genom Bioinform, 5, lqad022, 2023
  20. Design and Synthesis of Orexin 1 Receptor-Selective Agonists, J Med Chem, 66, 5453-5464, 2023
  21. COL1A2 inhibition suppresses glioblastoma cell proliferation and invasion, J Neurosurg, 138, 639-648, 2023
  22. The molecules and their functions involved in transport, Clinical Neuroscience, 40(12), 1531-1534, 2022
  23. ★, Blood-arachnoid barrier as a dynamic physiological and pharmacological interface between cerebrospinal fluid and blood, Drug Delivery to the Brain, 93-121, 2022
  24. Pharmacoproteomics of Brain Barrier Transporters and Substrate Design for the Brain Targeted Drug Delivery, Pharm Res, 39, 1363-1392, 2022
  25. Quantitative Targeted Absolute Proteomics for Better Characterization of an In Vitro Human Blood-Brain Barrier Model Derived from Hematopoietic Stem Cells, Cells, 11, 3963, 2022
  26. Proteomics-Based Transporter Identification by the PICK Method: Involvement of TM7SF3 and LHFPL6 in Proton-Coupled Organic Cation Antiport at the Blood-Brain Barrier, Pharmaceutics, 14, 1683, 2022
  27. ★, ssPalm-based lipid nanoparticles achieve efficient mRNA transfection in brain capillary endothelial cells, Pharmaceutics, 14, 1560, 2022
  28. Discovery of novel orexin receptor antagonists using a 1,3,5-trioxazatriquinane bearing multiple effective residues (TriMER) library, Eur J Med Chem, 240, 114505, 2022
  29. ★, Proteomics-based investigation of cerebrovascular molecular mechanisms in cerebral amyloid angiopathy by the FFPE-LMD-PCT-SWATH method, Fluids Barriers CNS, 19, 56, 2022
  30. Upregulation of ribosome complexes at the blood-brain barrier in Alzheimer's disease patients, J Cereb Blood Flow Metab, 42, 2134-2150, 2022
  31. Zinc transport via ZNT5-6 and ZNT7 is critical for cell surface glycosylphosphatidylinositol-anchored protein expression, J Biol Chem, 298, 102011, 2022
  32. Regional Differences in the Absolute Abundance of Transporters, Receptors and Tight Junction Molecules at the Blood-Arachnoid Barrier and Blood-Spinal Cord Barrier among Cervical, Thoracic and Lumbar Spines in Dogs, Pharm Res, 39, 1393-1413, 2022
  33. ★, A human blood-arachnoid barrier atlas of transporters, receptors, enzymes, and tight junction and marker proteins: Comparison with dog and pig in absolute abundance, J Neurochem, 161, 187-208, 2022
  34. SWATH-Based Comprehensive Determination of the Localization of Apical and Basolateral Membrane Proteins Using Mouse Liver as a Model Tissue, Biomedicines, 10, 383, 2022
  35. Activation of Annexin A2 signaling at the blood-brain barrier in a mouse model of multiple sclerosis, J Neurochem, 160, 662-674, 2022
  36. Identification and Validation of Combination Plasma Biomarker of Afamin, Fibronectin and Sex Hormone-Binding Globulin to Predict Pre-Eclampsia, Biol Pharm Bull, 44, 804-815, 2021
  37. An Atlas of the Quantitative Protein Expression of Anti- Epileptic-Drug Transporters, Metabolizing Enzymes and Tight Junctions at the Blood-Brain Barrier in Epileptic Patients, Pharmaceutics, 13, 2122, 2021

Invited Lecture, Oral Presentation, Poster Presentation

  1. CLDN5-related neurological disease, Yosuke Hashimoto, Gergő Porkoláb, Natalie Hudson, Chris Greene, Karine Poirier, Nathalie Boddaert, Arnold Munnich, Yasuo Uchida, Matthew Campbell, 8th Mini-Symposium on the Blood–Brain Barrier, 2026/03/28, With Invitation, English, Szeged, Hungary
  2. Integrated proteomic analysis of resected tumor tissues and longitudinally collected plasma from patients with glioblastoma, Xiuyuan Zhan, Adam McGlinchey, Angela Garcia-Gallardo, Jeffrey OCallaghan, Yosuke Hashimoto, Yasuo Uchida, Kieron Sweeney, Donncha OBrien, Matthew Campbell, 8th Mini-Symposium on the Blood–Brain Barrier, 2026/03/28, Without Invitation, English, Szeged, Hungary
  3. Next generation quantitative proteomics opens up the new fields of CNS barrier studies, Yasuo Uchida, The first knowledge exchange between Korean MPS engineers and Japanese barriologists, 2025/10/25, With Invitation, English, Hiroshima
  4. Identification of novel negative regulators of claudin-5 in vascular endothelial cells by genome-wide screening, Haruka Ono, Yosuke Hashimoto, Gergő Porkoláb, Natalie Hudson, Jeffrey OCallaghan, Nicole Hanley, Chris Greene, Yasuo Uchida, Mária A. Deli, Matthew Campbell, The first knowledge exchange between Korean MPS engineers and Japanese barriologists, 2025/10/25, Without Invitation, English, Hiroshima
  5. A single nucleotide polymorphism in claudin5 gene attenuates the binding ability to Pumilio RNA binding protein, Haruaki Ishikawa, Yosuke Hashimoto, Chris Greene, Nicole Hanley, Natalie Hudson, David Henshall, Kieron J. Sweeney, Donncha F. OBrien, Yasuo Uchida, Matthew Campbell, The first knowledge exchange between Korean MPS engineers and Japanese barriologists, 2025/10/25, Without Invitation, English, Hiroshima
  6. Elucidation of the in vivo efflux transport by peptide transporter PEPT2 at the blood-arachnoid-barrier in the elimination of beta-lactam antibiotics from CSF, Atsuki Takata, Yosuke Hashimoto, Masashi Kawami, Yasuo Uchida, The first knowledge exchange between Korean MPS engineers and Japanese barriologists, 2025/10/25, Without Invitation, English, Hiroshima
  7. Unraveling APOE4-Driven Pathogenic Mechanisms of Alzheimers Disease through Highly Deep Quantitative Proteomics, Yuki Maeda, Yosuke Hashimoto, Yoshiko Takebayashi, Ishikawa Ruoyi, Yu Yamazaki, Hiroshi Shimizu, Maiko Ono, Yuhei Takado, Hirofumi Maruyama, Yasuo Uchida, The first knowledge exchange between Korean MPS engineers and Japanese barriologists, 2025/10/25, Without Invitation, English, Hiroshima
  8. Spatial proteomics using AI-assisted laser microdissection to comprehensively quantify the absolute abundance of ECM proteins in region of interest in tissues, Yasuo Uchida, International Symposium on Multimodal ECM, 2025/09/03, Without Invitation, English, Gotenba, Japan
  9. Bridging targeted metabolomics to global proteomics approach to clarify ribavirin-induced resistance in breast cancer MCF-7 cells, Masashi Kawami, Airi Fukushima, Ryoko Yumoto, Mikihisa Takano, and Yasuo Uchida, 2024 ISSX/JSSX Meeting, 2024/09/15, Without Invitation, English, HAWAI
  10. Highly deep quantitative proteomics elucidate the mechanism of alzheimers disease targeting reactive strocyte, Yuki Maeda, Masashi Kawami, Yurika Abe, Hiroshi Shimizu, Jun Nagai, Maiko Ono, Yuhei Takdo, and Yasuo Uchida, 2024 ISSX/JSSX Meeting, 2024/09/15, Without Invitation, English, HAWAI
  11. Quantitative proteomics-based identification of novel therapeutic targets for progressive supranuclear palsy using post-mortem human brain, Yuta Kumagai, Masashi Kawami, Yurika Abe, Hiroshi Shimizu, Jun Nagai, Maiko Ono, Yuhei Takdo, and Yasuo Uchida, 2024 ISSX/JSSX Meeting, 2024/09/15, Without Invitation, English, HAWAI
  12. Next generation quantitative proteomics-based central nervous system barrier studies, Yasuo Uchida, 2024 ISSX/JSSX Meeting, 2024/09/15, Without Invitation, English, HAWAI
  13. Quantitative proteomics using paraffin sections: how to achieve efficient protein extraction, Yasuo Uchida, JPrOS2024 & JSCP20th, 2024/06/26, With Invitation, Japanese, Aomori
  14. Quantitative proteomic studies of the central nervous system barrier and brain pathology targeting neurological disease treatment, Yasuo Uchida, The 39th Annual Meeting of the Academy of Pharmaceutical Science and Technology, Japan (APSTJ), 2024/05/23, With Invitation, Japanese, Kobe
  15. Pathological proteomics research using human brain tissue from the Brain Bank, the pride of Japan, Yasuo Uchida, The 144th Annual Meeting of the Pharmaceutical Society of Japan, 2024/03/28, With Invitation, Japanese, Yokohama
  16. Next Generation Quantitative Proteomics Opens Up New Dimensions in Central Nervous System Barrier Research, Yasuo Uchida, The 149th Regular Meeting of Chugoku-Shikoku Branch of the Japanese Pharmaceutical Society, 2024/01/27, With Invitation, Japanese, Hiroshima
  17. Quantitative proteomics-based drug transport studies, Yasuo Uchida, Drug Discovery Pharmacokinetics Forum in Kanazawa, 2024/01/15, With Invitation, Japanese, Kanazawa University
  18. Quantitative membrane protein proteomics to elucidate the molecular mechanisms of transport in central tissues, Yasuo Uchida, 2023 Annual conference of the Membrane Society of Japan, 2023/11/20, With Invitation, Japanese, Tokyo
  19. Next generation quantitative proteomics opens up the new fields of central nervous system barrier studies, Yasuo Uchida, Korean Society of Applied Pharmacology (KSAP) annual meeting 2023, 2023/10/06, With Invitation, English, Korea
  20. The next generation of CNS disease treatment pioneered by the latest protein research, Yasuo Uchida, R5 Hiroshima Pharmacist Seminar, 2023/07/30, With Invitation, Japanese, Hiroshima
  21. Central nervous system barrier quantitative proteomics using human clinical specimens, Yasuo Uchida, JPrOS2023(21st JHUPO) Annual Meeting, 2023/07/24, With Invitation, Japanese, Niigata
  22. Metal traffic research using next-generation quantitative proteomics, Yasuo Uchida, The 23rd Annual Meeting of the Protein Science Society of Japan, 2023/07/05, With Invitation, Japanese, Nagoya
  23. Next generation quantitative proteomics opens up the new fields of CNS barrier studies, Yasuo Uchida, CVB2023 conference, 2023/06/18, With Invitation, English, Uppsala, Sweden
  24. Drug transporter studies in the central nervous system barrier using human postmortem brains, Yasuo Uchida, 64th Annual Meeting of the Japanese Society of Neurology, 2023/05/31, With Invitation, Japanese, Tokyo
  25. Proteomic measurements of the neurovascular units surrounding astrocytes, Yasuo Uchida, 34th Annual Clinical MR Brain Function Research Conference, 2023/05/13, With Invitation, Japanese, Tokyo
  26. Quantitative proteomics research for the effective use of human postmortem brains, Yasuo Uchida, The 112th Annual Meeting of the Japanese Society of Pathology, 2023/04/13, With Invitation, Japanese, Shimonoseki
  27. Next-generation quantitative proteomics opens up new horizons in CNS research, Y Uchida, 6th Mass Spectrometry Society of Japan, 2023/03/30, With Invitation, Japanese, Sendai
  28. Mechanisms of brain-selective migration of exosomes from metastatic melanoma in the brain, Y Uchida, 2022 conference of extracellular fine particles, 2023/01/31, Without Invitation, Japanese, Kumamoto
  29. New horizons in CNS research opened up by next-generation quantitative proteomics, Y Uchida, Brain Molecular Exploration seminar, 2022/12/26, With Invitation, Japanese, Tokyo
  30. Discovery for new substrates for MFSD10, a transporter highly expressed in the blood-brain barrier, Rhalib reda Akagawa, Tetsu Sato, Taiho Kambe, Yasuo Uchida, 61st Annual Meeting of the Tohoku Branch of the Pharmaceutical Society of Japan, 2022/11/27, Without Invitation, Japanese, online
  31. Blood-brain barrier MFSD10 limits drug brain migration and central effects of drugs, Tetsu Sato, Rhalib reda Akagawa, Yasuo Uchida, 61st Annual Meeting of the Tohoku Branch of the Pharmaceutical Society of Japan, 2022/11/27, Without Invitation, Japanese, online
  32. Next-generation proteomics opens up new central nervous system barrier, Y Uchida, 21st Seminar for Young Researchers in Medical Pharmacy, 2022/11/12, With Invitation, Japanese, Sendai
  33. Bottom-up construction of brain-shaped nanoparticles for a breakthrough in the delivery of polymeric medicines to the brain, Y Uchida, 2nd meeting of bottom-up biotech, 2022/09/26, Without Invitation, Japanese, Rusutsu
  34. Report on collaborative research based on the quantitative proteomics SWATH method, Y Uchida, 2022 conference of biometal science, 2022/09/03, Without Invitation, Japanese, Rusutsu
  35. Central nervous system barrier research using quantitative proteomics, Y Uchida, 5th conference of extracellular fine particles, 2022/07/21, Without Invitation, Japanese, online
  36. Next generation quantitative proteomics and its application to metal transport study, Y Uchida, The 22nd Annual Meeting of the Protein Science Society of Japan, 2022/06/09, With Invitation, Japanese, Tsukuba
  37. New central barrier opened up by new technologies, Y Uchida, APSTJ 37th annual meeting, 2022/05/26, With Invitation, Japanese, Kyoto
  38. The role of the blood-brain barrier, blood-arachnoid barrier and blood-cerebrospinal fluid barrier in metal dynamics in the human brain, Y Uchida, 2022 1st meeting of biometal science, 2022/05/21, Without Invitation, Japanese, Tokyo
  39. Establishment of a diagnostic basis for personalised pharmacotherapy of refractory cancers based on reconstruction of the molecular clouding environment of cancer cells, Y Uchida, 6th meeting of molecular clouding chemistry, 2022/01/27, Without Invitation, Japanese, online

Awards

  1. 2023/04/19, 2023 the MEXT Young Scientists' Prize, Ministry of Education, Culture, Sports, Science and Technology, Human central nervous system study based on the development of human tissue quantitative proteomics
  2. 2022/04/01, CREST extracellular fine particle Young Innovator Award, JST CREST

External Funds

Acceptance Results of Competitive Funds

  1. Grant-in-Aid for Scientific Research (B), Establishing Treatment Strategies for Abnormalities in the Tight Junctions of the Blood-Brain Barrier Common to Various Central Nervous System Disorders, 2026, 2028
  2. Grant-in-Aid for Scientific Research (C), Targeting Aged Microglia Dysfunction: A Novel Therapeutic Approach for Geriatric Psychiatric Diseases, 2025, 2027
  3. Grant-in-Aid for Scientific Research (C), Creation of novel blood tumor markers for urologic cancers by focusing on genomic mutations, 2025, 2027
  4. Grant-in-Aid for Transformative Research Areas (A), Development of a comprehensive and accurate absolute protein and phosphorylation quantification method applicable to diverse organisms, 2025, 2026
  5. Grants-in-Aid for Scientific Research, Challenging Research (Exploratory), 2024, 2025
  6. Grant-in-Aid for Transformative Research Areas (A), 2024, 2025
  7. Grants-in-Aid for Scientific Research, Scientific Research(B), 2023, 2025
  8. Grants-in-Aid for Scientific Research, Scientific Research(A), 2022, 2025
  9. Grants-in-Aid for Scientific Research, Innovative Areas (Research in a proposed research area) Single-year Grants, 2022, 2023
  10. Grants-in-Aid for Scientific Research, Transformative Research Areas (A), 2022, 2023
  11. AMED, Research and Development Grants for Dementia, 2022, 2024
  12. CREST Young Scientist Challenge, 2022, 2022
  13. AMED, Practical Research for Innovative Cancer Control, 2021, 2023
  14. Grants-in-Aid for Scientific Research, Challenging Research (Exploratory), 2021, 2022
  15. Grants-in-Aid for Scientific Research, Scientific Research(B), 2020, 2022
  16. Grants-in-Aid for Scientific Research, Fund for the Promotion of Joint International Research (Fostering Joint International Research (A)), 2019, 2023